CSBR vs PATH
Champions Oncology Inc (CSBR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CSBR and PATH stock pages for the full models.
Not investment advice.